NZ510628A - Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal - Google Patents
Use of a tetracycline derivative for reducing the risk of cataract formation in a mammalInfo
- Publication number
- NZ510628A NZ510628A NZ510628A NZ51062899A NZ510628A NZ 510628 A NZ510628 A NZ 510628A NZ 510628 A NZ510628 A NZ 510628A NZ 51062899 A NZ51062899 A NZ 51062899A NZ 510628 A NZ510628 A NZ 510628A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hydrogen
- amino
- chloro
- halogen
- acylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10205698P | 1998-09-28 | 1998-09-28 | |
PCT/US1999/022354 WO2000018353A2 (fr) | 1998-09-28 | 1999-09-28 | Nouvel inhibiteur de formation de cataracte |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ510628A true NZ510628A (en) | 2003-08-29 |
Family
ID=22287890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ510628A NZ510628A (en) | 1998-09-28 | 1999-09-28 | Use of a tetracycline derivative for reducing the risk of cataract formation in a mammal |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1124558A4 (fr) |
JP (1) | JP2002525299A (fr) |
KR (1) | KR20010073190A (fr) |
AU (1) | AU759372B2 (fr) |
CA (1) | CA2343038A1 (fr) |
NZ (1) | NZ510628A (fr) |
WO (1) | WO2000018353A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69932846T2 (de) * | 1998-11-18 | 2007-03-15 | Collagenex Pharmaceuticals, Inc. | Neue 4-dedimethylaminotetracyclinderivate |
US6506740B1 (en) | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
NZ529308A (en) * | 2001-04-05 | 2005-03-24 | Collagenex Pharm Inc | Tetracycline compounds comprising a tetracycline and a controlled release agent to provide delivery at a dose below that required for antibiotic activity |
EP1383508B1 (fr) * | 2001-04-05 | 2006-06-21 | Collagenex Pharmaceuticals, Inc. | Doxycycline destinee au traitement de l'acne |
JP2005514410A (ja) * | 2002-01-08 | 2005-05-19 | パラテック ファーマシューティカルズ インコーポレイテッド | 4−デジメチルアミノテトラサイクリン化合物 |
PT1615622E (pt) | 2003-04-07 | 2012-10-17 | Supernus Pharmaceuticals Inc | Formulações de doxiciclinas de dose única diária |
CA2732883C (fr) | 2008-08-08 | 2018-03-06 | Tetraphase Pharmaceuticals, Inc. | Composes de tetracycline c7-fluorosubstituee |
WO2010129057A2 (fr) | 2009-05-08 | 2010-11-11 | Tetraphase Pharmaceuticals, Inc. | Composés de tétracycline |
WO2011025982A2 (fr) | 2009-08-28 | 2011-03-03 | Tetraphase Pharmaceuticals, Inc. | Composés tétracycline |
SI2890673T1 (sl) | 2012-08-31 | 2019-05-31 | Tetraphase Pharmaceuticals, Inc. | Spojine tetraciklina |
US10961190B2 (en) | 2016-10-19 | 2021-03-30 | Tetraphase Pharmaceuticals, Inc. | Crystalline forms of eravacycline |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS275231B2 (en) * | 1989-09-29 | 1992-02-19 | Ustav Makormolekularni Chemie | Medicine bottle |
JPH0515954A (ja) * | 1991-07-10 | 1993-01-26 | Harima Ceramic Co Ltd | ポーラス質スライデイングノズルプレート |
US5340572A (en) * | 1993-02-08 | 1994-08-23 | Insite Vision Incorporated | Alkaline ophthalmic suspensions |
JPH09315954A (ja) * | 1996-05-30 | 1997-12-09 | Kita:Kk | 眼科手術後の眼組織混濁防止剤。 |
US5814655A (en) * | 1996-11-14 | 1998-09-29 | Insite Vision Incorporated | Non-steroidal ophthalmic mixtures |
US5929055A (en) * | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
-
1999
- 1999-09-28 NZ NZ510628A patent/NZ510628A/en unknown
- 1999-09-28 KR KR1020017003876A patent/KR20010073190A/ko not_active Application Discontinuation
- 1999-09-28 WO PCT/US1999/022354 patent/WO2000018353A2/fr not_active Application Discontinuation
- 1999-09-28 CA CA002343038A patent/CA2343038A1/fr not_active Abandoned
- 1999-09-28 EP EP99949910A patent/EP1124558A4/fr not_active Withdrawn
- 1999-09-28 JP JP2000571875A patent/JP2002525299A/ja active Pending
- 1999-09-28 AU AU62684/99A patent/AU759372B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP1124558A4 (fr) | 2004-10-27 |
AU6268499A (en) | 2000-04-17 |
EP1124558A2 (fr) | 2001-08-22 |
WO2000018353A2 (fr) | 2000-04-06 |
KR20010073190A (ko) | 2001-07-31 |
CA2343038A1 (fr) | 2000-04-06 |
JP2002525299A (ja) | 2002-08-13 |
WO2000018353A3 (fr) | 2000-07-06 |
AU759372B2 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6914057B1 (en) | Inhibitor of cataract formation | |
AU2002256092B2 (en) | Controlled delivery of tetracycline compounds and tetracycline derivatives | |
US5597560A (en) | Diclofenac and tobramycin formulations for ophthalmic and otic topicaluse | |
US20040171591A1 (en) | Method for decreasing low density lipoprotein | |
AU2002256092A1 (en) | Controlled delivery of tetracycline compounds and tetracycline derivatives | |
AU759372B2 (en) | A novel inhibitor of cataract formation | |
CA2737475A1 (fr) | Formulations stabilisant la tetracycline | |
AU2003226112B2 (en) | Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins | |
AU2005222937B2 (en) | Method for treating aortic stenosis with non-antibacterial tetracycline formulations | |
NZ538198A (en) | Method for reducing C-reactive protein (CRP) levels by administering a non-antibacterial tetracycline formulation or a low dose of an antibacterial tetracycline formulation | |
NZ522733A (en) | Non-antibacterial tetracycline as anti-fungal agents | |
WO2004054509A2 (fr) | Tetracyclines en tant qu'agents antifongiques pour le traitement de la teigne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |